MICROBPLEX, INC.
Medtech · Defunct
MENSA diagnostic platform that isolates circulating antibody-secreting cells from blood and cultures them to detect pathogen-specific antibodies for early Lyme disease diagnosis
- Grants
- $895K
- 2 awards
- Sector median: 1
- Raised
- —
- No Form D on record
- Contracts
- $289K
- 2 awards · Health and Human S
- #431 of 4531 in medtech
- Patents
- 4
- 1 granted · 3 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓2013201420152016201720182019
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal contract | Department of Health and Human Services · Lab Supplies | $139,200 | |
| Federal contract | Department of Health and Human Services · SBIR Phase I Topic OO6 Igf::ot::igf | $149,999 | |
| Federal grant | Department of Health and Human Services · Phase I · Novel Diagnostics for Early Lyme Disease | $596,428 | |
| Federal grant | Department of Health and Human Services · Phase I · Novel Diagnostics for Early Lyme Disease | $298,875 |
Federal grant · SBIR/STTRFederal contract · USAspending
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 428 | ACOUSTICABIO, INC. | $295K | — |
| 429 | EIGEN HEALTH SERVICES LLC | $294K | — |
| 430 | NEXOGEN INC | $293K | — |
| 431 | MICROBPLEX, INC. | $289K | — |
| 432 | BDYWR, LLC | $275K | — |
| 433 | JBS SCIENCE INC | $274K | — |
| 434 | HYDROCISION INC | $252K | $6.2M |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Patents
- Methods Of Diagnosing Lyme Diseaseapplication
- Media Elaborated With Newly Synthesized Antibodies (mensa) And Uses Thereofapplication
- Media Elaborated with Newly Synthesized Antibodies (MENSA) and Uses Thereofgranted
- Methods Of Diagnosing Lyme Diseaseapplication
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.